We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
An online gallery comprised of the best art from the very best artists. Rise Art uses artificial intelligence alongside consumer psychology to produce personalised recommendations, which customers can 'trial' out in their personal spaces, or workplaces, to see if it meets their desires. In 2017, the company had grown with £1m in sales, almost twice YoY.
days to go: Expired investment: £690,680
The British Journal of Photography (BJP) is a monthly magazine dedicated to comtemporary photography. In the last 3 years, the print magazine has been completely re-designed and since then, BJP have launched new apps, new events and awards aimed at capturing the next generation of readers. 
days to go: Expired investment: £399,720
Cell Guidance Systems is developing a technology called PODS (Polyhedrin Delivery System) PODS allow them to deliver therapeutic proteins accurately and over long periods of time. PODS enable proteins to treat diseases, such as Parkinson’s disease and osteoarthritis.
days to go: Expired investment: £836,370
Landlord Referencing.co.uk provides the safest and most comprehensive tenant referencing services in the UK. A huge database of tenant references provided by landlords for landlords has been built up over a 5 year period by the ... Read more
days to go: Expired investment: £25,886
Maecenas is a fine art investment platform, allowing collectors to raise funds and investors to own a piece of fine art they would not normally be able to afford such as a picasso or even a Rembrandt! The investment made in the Artwork can easily be re-sold using the Maecenas platform and all investments are fully protected by insurance and a strong legal framework. 
days to go: Expired investment: £218,249
Brickowner aims to become the leading service provider for property developers and asset managers, ensuring benefits for both parties. The company asserts that it undertakes background checks of investors on its portal for the benefit of asset managers. It also ensures that investors can easily navigate its portal and find deals that suit their financial appetite. Brickowner successfully exited five investment rounds despite two investments happening in the wake of COVID-19. The platform has over 3,000 investors registered with over 700 active investors. It has overseen over £15 million worth of investments on its portal till date. Brickowner will use the investment towards technology up-gradation, develop its B2B capacity, and increase marketing initiatives to support company growth

Pitch Rated

56%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £290,362
Flooring Hut is a UK-based technology company that aims to disrupt the UK flooring industry valued at £2bn in 2017. Touted as the smarter way to buy new carpets & flooring, Flooring Hut has made 24,000+ online sales across domestic and trade sectors by building a huge network of independent installers. The company's USP is to connect a disjointed market and allow customers access to value products, samples, leading brands and a suitable, vetted local installer to perform the work. The key to its success to date has been a consistent and reliable mix of pricing, availability, and selection. Till date, the company has 786 registered trade customers, 140+ Flooring Hut Installer Network of members, and 12,000 products available for sale. With the proceeds, the company will develop its self-service platform functionality for customers and expand its reach on social media and affiliate marketing.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £57,077
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £326,190
Vyomm is a property platform based in London for sellers, buyers and agents of Prime and Super Prime properties. Vyomm aims to become a preferred destination for Luxury, Exclusive, and Off Market Properties in London. Their engaging platform has gained substantial traction with several hundred Prime Central London properties. They have featured in Tatler, PrimeResi, Mirror and 12 other publications. With the investment, Vyomm plans to onboard top estate agents in London, expand into Asia, Europe and the USA, marketing and developmental operations.

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £178,280
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £200,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph